Scientists at the McGovern Institute and the Broad Institute of MIT and Harvard have reengineered a compact RNA-guided enzyme ...

CRISPR Therapeutics benefits from Casgevy’s approval and a deep pipeline, despite early rollout hurdles and cost challenges.

A federal appeals court said the patent office made legal errors in awarding foundational patents for CRISPR-Cas9 to the ...

Scientists in the US have performed the first personalised gene therapy on a child with a life-threatening rare disease, ...

A tailored CRISPR base-editing therapy was given for the first time to an infant who was born with a rare genetic disease, ...

Recent biotechnological innovations like genome — editing in crop breeding are seen as major achievements to address the challenges of food security and also to reduce the burden of agriculture to ...

In a precedential opinion issued on Monday, the U.S. Court of Appeals for the Federal Circuit (CAFC) vacated and remanded a ...

Ask scientists which gene-editing tool is most needed to advance gene therapy, and they'd probably describe a system that's ...

About 150 people in Singapore have transthyretin amyloid cardiomyopathy. Read more at straitstimes.com. Read more at ...

Vienna, Austria – May 9th 2025 – Biomay, a leading manufacturer of recombinant proteins, today announced the commercial availability of its CRISPR/Cas9 nuclease, marking a significant addition to its ...

A range of other rare inherited diseases are now likely to be curable by similar procedures, the research team said ...